Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | methylhexadecanoic acid | 215 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 226 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 243 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 246 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 266 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 272 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 277 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 278 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 288 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 296 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 308 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 309 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 330 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 333 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 353 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 363 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 370 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 386 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 396 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 400 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 405 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 413 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 419 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 432 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 434 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 448 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 457 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 458 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 465 | Counts | 65-69 | Female | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 467 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 488 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 509 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 517 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 518 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 520 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 520 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 521 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 527 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 542 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 543 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 545 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 548 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 552 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 560 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 560 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 562 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 563 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 594 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 597 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 599 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 599 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 607 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 616 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 639 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 647 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 647 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 655 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 655 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 666 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 678 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 680 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 682 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 687 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 689 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 692 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 694 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 698 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 701 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 702 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 703 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 706 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 707 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 713 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 715 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 716 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 717 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 726 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 728 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 734 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 738 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 742 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 743 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 745 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 746 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 746 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 748 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 750 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 752 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 752 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 753 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 757 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 758 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 761 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 763 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 765 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 765 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 772 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 777 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 777 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 781 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 782 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 783 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 784 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 787 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 790 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 791 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 799 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 802 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 804 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 807 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 807 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 810 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 811 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 816 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 822 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 831 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 831 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 837 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 842 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 844 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 845 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 849 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 851 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 853 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 854 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 854 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 857 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 858 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 858 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 862 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 862 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 870 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 871 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 875 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 877 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 883 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 887 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 890 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 890 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 895 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 896 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 898 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 899 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 902 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 903 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 906 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 909 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 920 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 928 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 936 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 936 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 948 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 955 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 957 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 960 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 965 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 967 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 967 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 969 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 971 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 976 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 978 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 979 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 982 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 985 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 987 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 987 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 992 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 993 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1001 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1002 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1002 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1003 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1008 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1019 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1021 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1021 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1022 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1031 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1038 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1040 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1041 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1043 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1048 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1052 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1053 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1053 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1054 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1054 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1055 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1057 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1063 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1066 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1067 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1068 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1068 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1068 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1073 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1076 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1079 | Counts | 55-59 | Male | Former | Squamous cell |
Return to search page